FREE Case Review (866) 588-0600

Taxotere Lawsuit Filed in Ohio

An Ohio woman who alleges she had permanent hair loss (“alopecia”) after chemotherapy with Taxotere has filed a products liability lawsuit against the manufacturer.

An Ohio woman has filed a product liability lawsuit against Sanofi alleging that its chemotherapy drug Taxotere (generic: docetaxel) caused her to develop permanent hair loss, a condition known as alopecia.

Free Confidential Lawsuit Evaluation: If you or a loved one went bald, suffered permanent hair loss or alopecia from Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

March 18, 2016 – According to the lawsuit, plaintiff Hattie Carson was prescribed Taxotere in 2004 shortly after being diagnosed with breast cancer. When her hair didn’t grow back in 6 months, she was diagnosed with alopecia.

Following a December 2015 warning by the U.S. Food & Drug Administration (FDA) and subsequent update to Taxotere’s labeling regarding an increased risk for permanent hair loss, Carson filed a complaint in the U.S. District Court, Northern District of Ohio (case number 1:16-cv-00165).

“Although alopecia is a common side effect related to chemotherapy drugs, permanent alopecia is not,” the lawsuit states. “Defendants, through its publications and marketing material, misled Plaintiff, the public, and the medical community to believe that, as with other chemotherapy drugs that cause alopecia, patients’ hair would grow back.”

Other Taxotere lawsuits have suggested that Sanofi’s own studies found that at least 3% of cancer patients suffered persistent or permanent hair loss after being treated with the drug. Another study found that just over 6% of breast cancer patients succeeded in growing back less than 50% of their hair.

Although temporary hair loss is a common side effect of chemotherapy treatment, permanent alopecia is not. A 2013 study published by the National Cancer Research Institute (NCRI) found permanent hair loss as a side effect in 10-15% of patients treated with Taxotere.

Canada and Europe were alerted to the alopecia risk with Taxotere in 2012 and 2005, respectively. It’s unclear why Sanofi waited until winter 2015 to warn American health officials about the problem.

According to Health Canada, some 65,000 Canadians — including approximately 6,000 breast cancer patients — underwent treatment with Taxotere in 2009 alone. Various plaintiffs have alleged they were never given the choice whether to be treated with Taxotere or Taxol (generic: paclitaxel), another chemotherapy medication that only causes a small amount of temporary hair loss. These people claim had they known about the risk of permanent alopecia with Taxotere, they would have opted to be treated with Taxol.

Do I Have a Taxotere Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.

Free Confidential Case Evaluation: Again, if you were injured by Taxotere side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition